| Dr Michael Adu, DO | |
|
8131 Spyglass Hill Dr, Fayetteville, PA 17222-5500 | |
| (717) 261-5211 | |
| (717) 264-5418 |
| Full Name | Dr Michael Adu |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 8131 Spyglass Hill Dr, Fayetteville, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194341677 | NPI | - | NPPES |
| Entity Name | Summit Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306840814 PECOS PAC ID: 5496659484 Enrollment ID: O20031121000259 |
News Archive
A University of Colorado Cancer study published today in the Journal of the American Medical Informatics Association describes a new tool that interprets the raw data of whole exome tumor sequencing and then matches the cancer's unique genetics to FDA-approved targeted treatments.
IntegraMed America, Inc., a leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, announced today that it has entered into a definitive agreement to be acquired by affiliates formed by Sagard Capital Partners, L.P., an investment fund and IntegraMed shareholder, for $14.05 per share in cash, or a total equity purchase price of $169.5 million.
Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced that Alimera Sciences Limited, its European subsidiary based in London, revealed interim six-month data on ILUVIEN (Fluocinolone Acetonide 190 micrograms intravitreal implant in applicator) from the ongoing study referred to as RESPOND, a non-Randomised, open-label, multicenter phase 4 pilot study on the Effect and Safety of ILUVIEN Fluocinolone Acetonide in chronic diabetic macular edema Patients cOnsidered iNsufficiently responsive to available therapies with or without intravitreal corticosteroiD therapy.
Students from four of Arizona State University's graduate programs traveled to a country known as the Land of 1,000 Hills to study health care and building design in one of Africa's most impoverished areas.
› Verified 8 days ago
| Entity Name | Wellspan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
A University of Colorado Cancer study published today in the Journal of the American Medical Informatics Association describes a new tool that interprets the raw data of whole exome tumor sequencing and then matches the cancer's unique genetics to FDA-approved targeted treatments.
IntegraMed America, Inc., a leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, announced today that it has entered into a definitive agreement to be acquired by affiliates formed by Sagard Capital Partners, L.P., an investment fund and IntegraMed shareholder, for $14.05 per share in cash, or a total equity purchase price of $169.5 million.
Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced that Alimera Sciences Limited, its European subsidiary based in London, revealed interim six-month data on ILUVIEN (Fluocinolone Acetonide 190 micrograms intravitreal implant in applicator) from the ongoing study referred to as RESPOND, a non-Randomised, open-label, multicenter phase 4 pilot study on the Effect and Safety of ILUVIEN Fluocinolone Acetonide in chronic diabetic macular edema Patients cOnsidered iNsufficiently responsive to available therapies with or without intravitreal corticosteroiD therapy.
Students from four of Arizona State University's graduate programs traveled to a country known as the Land of 1,000 Hills to study health care and building design in one of Africa's most impoverished areas.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Adu, DO 601 Memory Ln, York, PA 17402-2231 Ph: (717) 261-5211 | Dr Michael Adu, DO 8131 Spyglass Hill Dr, Fayetteville, PA 17222-5500 Ph: (717) 261-5211 |
News Archive
A University of Colorado Cancer study published today in the Journal of the American Medical Informatics Association describes a new tool that interprets the raw data of whole exome tumor sequencing and then matches the cancer's unique genetics to FDA-approved targeted treatments.
IntegraMed America, Inc., a leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, announced today that it has entered into a definitive agreement to be acquired by affiliates formed by Sagard Capital Partners, L.P., an investment fund and IntegraMed shareholder, for $14.05 per share in cash, or a total equity purchase price of $169.5 million.
Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced that Alimera Sciences Limited, its European subsidiary based in London, revealed interim six-month data on ILUVIEN (Fluocinolone Acetonide 190 micrograms intravitreal implant in applicator) from the ongoing study referred to as RESPOND, a non-Randomised, open-label, multicenter phase 4 pilot study on the Effect and Safety of ILUVIEN Fluocinolone Acetonide in chronic diabetic macular edema Patients cOnsidered iNsufficiently responsive to available therapies with or without intravitreal corticosteroiD therapy.
Students from four of Arizona State University's graduate programs traveled to a country known as the Land of 1,000 Hills to study health care and building design in one of Africa's most impoverished areas.
› Verified 8 days ago
Dr. George William Baker Jr., MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 130 E Main St, Fayetteville, PA 17222 Phone: 717-352-7881 Fax: 717-352-8850 | |
Dr. Paul Douglas Orange, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4225 Lincoln Way E, Fayetteville, PA 17222 Phone: 717-352-3616 Fax: 717-352-9013 | |
Leo E Kratz, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8131 Spyglass Hill Dr, Fayetteville, PA 17222 Phone: 717-749-3181 Fax: 717-349-3191 | |
Jonah Burke, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8131 Spyglass Hill Dr, Fayetteville, PA 17222 Phone: 717-749-3181 Fax: 717-349-3191 |